MIAMI, FL -- (MARKET WIRE) -- February 07, 2007 -- DOR BioPharma, Inc. (OTCBB: DORB) (DOR or the Company) announced that the company will sponsor a Graft versus Host Disease (GVHD) Working Committee at the 2007 Tandem Bone Marrow Transplant (BMT) Meeting to be held February 8-12, 2007 in Keystone, Co. The purpose of the Working Committee is to educate transplant practitioners and patient advocacy groups by reviewing the past year's research accomplishments as well as discuss current studies and the scientific activities for the coming year.
